Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Margaritis Avgeris

32PUBLICATIONS
55CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsHaematological tumoursCancer geneticsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

Sort by Publication Date:
|May 04, 2026
Delving into tRNA-derived small RNAs in multiple myeloma: elevated 3'U-tRF<sup>SerTGA</sup> leads to poor disease prognosis.

|Sep 09, 2025
Loss of METTL3 m6A methyltransferase results in short-term progression and poor treatment outcome of bladder cancer patients.

Katerina-Marina Pilala, Stella Koroneou, Maria-Alexandra Papadimitriou

|Sep 01, 2025
NEAT1 lncRNA overexpression results in short-term progression and poor treatment outcome in childhood B-ALL.

Marieta Xagorari, Antonios Marmarinos, Dimitrios Doganis

|Mar 26, 2025
Lifestyle and Biochemical Parameters That May Hamper Immune Responses in Pediatric Patients After Immunization with the BNT162b2 mRNA COVID-19 Vaccine.

Anthie Damianaki, Antonios Marmarinos, Margaritis Avgeris

|Apr 05, 2024
<i>MIR145</i> Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.

Katerina-Marina Pilala, Georgios Kotronopoulos, Panagiotis Levis

|Feb 28, 2024
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRF<sup>HisGTG</sup> results in patients' poor treatment outcome.

Konstantinos Soureas, Maria-Alexandra Papadimitriou, Panagiotis Malandrakis

Pageof 6

Frequent Collaborators

21 joint publications

Andreas Scorilas

6 joint publications

Meletios-Athanasios Dimopoulos

5 joint publications

Konstantina Panoutsopoulou

5 joint publications

Evangelos Terpos

5 joint publications

Katerina-Marina Pilala

4 joint publications

Christos K Kontos

3 joint publications

Ioannis Ntanasis-Stathopoulos

3 joint publications

Maria-Alexandra Papadimitriou

3 joint publications

Georgios Kotronopoulos

2 joint publications

Athanassios D Velentzas

Frequent Collaborators

21 joint publications

Andreas Scorilas

6 joint publications

Meletios-Athanasios Dimopoulos

5 joint publications

Konstantina Panoutsopoulou

5 joint publications

Evangelos Terpos

Top Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

5.7K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice:  A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.7K
See more related videos

Top Related Videos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos
07:24

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

5.7K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice:  A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

21.7K
See more related videos